Nothing Special   »   [go: up one dir, main page]

Saracli et al., 2015 - Google Patents

Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS)

Saracli et al., 2015

View HTML
Document ID
10337134310551446902
Author
Saracli M
Fothergill A
Sutton D
Wiederhold N
Publication year
Publication venue
Medical mycology

External Links

Snippet

Abstract MALDI-TOF MS can rapidly identify microorganisms to the species level and may be able to detect antimicrobial resistance. We evaluated the ability of this technology to detect triazole resistance in Candida species. 35 C. albicans, 35 C. glabrata, and 37 C …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures

Similar Documents

Publication Publication Date Title
Saracli et al. Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS)
Vella et al. Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization–time of flight mass spectrometry analysis
Marinach et al. MALDI‐TOF MS‐based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole
Marinach-Patrice et al. Rapid species diagnosis for invasive candidiasis using mass spectrometry
Sanguinetti et al. Susceptibility testing of fungi to antifungal drugs
Cassagne et al. Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory
Cuenca-Estrella et al. Detection and investigation of invasive mould disease
Burgel et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole
Cameron et al. Rapid evaporative ionisation mass spectrometry (REIMS) provides accurate direct from culture species identification within the genus Candida
Delavy et al. Machine learning approach for Candida albicans fluconazole resistance detection using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Dierig et al. The fast route to microbe identification: matrix assisted laser desorption/ionization—time of flight mass spectrometry (MALDI-TOF MS)
Feucherolles et al. Combination of MALDI-TOF mass spectrometry and machine learning for rapid antimicrobial resistance screening: The case of Campylobacter spp.
Robert et al. MALDI-TOF MS in a medical mycology laboratory: on stage and backstage
Axelsson et al. Rapid detection of antibiotic resistance in positive blood cultures by MALDI-TOF MS and an automated and optimized MBT-ASTRA protocol for Escherichia coli and Klebsiella pneumoniae
Florio et al. MALDI-TOF MS applications to the detection of antifungal resistance: state of the art and future perspectives
Dhieb et al. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata
Duettmann et al. Serum and urine galactomannan testing for screening in patients with hematological malignancies
Knabl et al. Antifungal susceptibility testing in Candida species: Current methods and promising new tools for shortening the turnaround time
Scapaticci et al. Phenotypic typing and epidemiological survey of antifungal resistance of Candida species detected in clinical samples of Italian patients in a 17 months’ period
Abe et al. Serum (1, 3)-beta-D-glucan is an inefficient marker of breakthrough candidemia
Wang et al. A genoproteomic approach to detect peptide markers of bacterial respiratory pathogens
Enroth et al. Evaluation of QuickFISH and maldi Sepsityper for identification of bacteria in bloodstream infection
Takeda et al. Species identification, antifungal susceptibility, and clinical feature association of Aspergillus section Nigri isolates from the lower respiratory tract
Jeddi et al. Performance assessment of two lysis methods for direct identification of yeasts from clinical blood cultures using MALDI-TOF mass spectrometry
Durán-Valle et al. Identification of clinical yeasts by Vitek MS system compared with API ID 32 C